Profile
| Metric | Value |
|---|---|
| Full Name | AptarGroup, Inc. |
| Ticker | NYSE: ATR |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aptar.com |
| Employees | 13,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $122.44 | |
| Price, 1D Change | +1.66% | |
| Market Cap | $8B | |
| TTM Dividend Yield | 1.49% | |
| PE Ratio | 19.62 | |
| Beta | 0.59 | |
| Revenue | $4B | |
| Revenue, 1Y Change | +2.74% | |
| EPS | $5.53 | |
| EPS, 1Y Change | +30.14% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.48 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.53 | |
| EPS Estimate | $5.72 | |
| EPS Est. Change | +3.39% | |
| Revenue | $3.58B | |
| Revenue Estimate | $3.69B | |
| Revenue Est. Change | +2.98% | |
| Current Price | $122.44 | |
| Price Target | - | $150.00 |
| Price Tgt. Change | - | +22.51% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.69 | $4.25 | -9.43% | |
| $5.38 | $5.53 | +2.69% | |
| $5.72 | N/A | +3.39% | |
| $5.58 | N/A | +0.99% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.49B | $3.49B | -0.01% | |
| $3.59B | $3.58B | -0.16% | |
| $3.69B | N/A | +2.98% | |
| $3.81B | N/A | +6.45% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -20.57% | |
| Price, 3Y | +7.35% | |
| Market Cap, 1Y | -21.62% | |
| Market Cap, 3Y | +8.04% | |
| Revenue, 1Y | +2.74% | |
| Revenue, 3Y | +11.02% | |
| EPS, 1Y | +30.14% | |
| EPS, 3Y | +53.56% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $122.44 | |
| SMA 200 | $139.37 | |
| SMA 200 vs Price | +13.83% | |
| SMA 50 | $120.68 | |
| SMA 50 vs Price | -1.44% | |
| Beta | 0.59 | |
| ATR | $2.77 | |
| 14-Day RSI | 52.22 | |
| 10-Day Volatility | 15.20% | |
| 1-Year Volatility | 24.96% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.48 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.40% | |
| Total Dividend | $1.72 | |
| Dividends Paid | $114.06M | |
| Payout Ratio | 30.48% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.58B | |
| EPS | $5.53 | |
| Gross Profit | $1.36B | |
| Gross Margin | 37.83% | |
| Operating Profit | $509.50M | |
| Operating Margin | 14.22% | |
| Net Income | $374.18M | |
| Net Margin | 10.45% | |
| EBITDA | $777.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.42 | |
| Current Ratio | 1.38 | |
| Quick Ratio | 0.95 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 4.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 19.62 | |
| PS Ratio | 2.19 | |
| PB Ratio | 2.90 | |
| EV/EBITDA | 11.24 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $2.47B | |
| Cash & Equivalents | $223.84M | |
| Total Assets | $4.43B | |
| Current Assets | $1.48B | |
| Total Liabilities | $1.95B | |
| Current Liabilities | $1.07B | |
| Total Debt | $1.09B | |
| Short Term Debt | $338.29M | |
| Accounts Payable | $295.97M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.07B | |
| Operating Expenses | $846.01M | |
| Cost Of Goods Sold | $2.23B | |
| SG&A | $582.23M | |
| D&A | $263.78M | |
| Interest Expense | $0.00 | |
| Income Tax | $95.59M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $643.41M | |
| CFI | -$396.72M | |
| CFF | -$225.34M | |
| Capex | $294.19M | |
| Free Cash Flow | $349.22M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Baird | → | |
| Wells Fargo | → | |
| Keybanc | ||
| Wells Fargo | → | |
| Raymond James | → | |
| Wells Fargo | → | |
| Raymond James | → | |
| Wells Fargo | → | |
| Raymond James | → |
Analyst sentiment
Institutional ownership
Screeners with ATR
Data Sources & References
- ATR Official Website www.aptar.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/896622/000089662225000033/0000896622-25-000033-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/896622/000089662225000007/0000896622-25-000007-index.htm
- ATR Profile on Yahoo Finance finance.yahoo.com/quote/ATR
- ATR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atr
FAQ
What is the ticker symbol for AptarGroup, Inc.?
The ticker symbol for AptarGroup, Inc. is NYSE:ATR
Does AptarGroup, Inc. pay dividends?
Yes, AptarGroup, Inc. pays dividends. The last payment was $0.48, with an ex-dividend date on October 23, 2025
What sector is AptarGroup, Inc. in?
AptarGroup, Inc. is in the Healthcare sector
What industry is AptarGroup, Inc. in?
AptarGroup, Inc. is in the Medical Instruments & Supplies industry
What country is AptarGroup, Inc. based in?
AptarGroup, Inc. is headquartered in United States
When did AptarGroup, Inc. go public?
AptarGroup, Inc. initial public offering (IPO) was on April 23, 1993
Is AptarGroup, Inc. in the S&P 500?
No, AptarGroup, Inc. is not included in the S&P 500 index
Is AptarGroup, Inc. in the NASDAQ 100?
No, AptarGroup, Inc. is not included in the NASDAQ 100 index
Is AptarGroup, Inc. in the Dow Jones?
No, AptarGroup, Inc. is not included in the Dow Jones index
When was AptarGroup, Inc. last earnings report?
AptarGroup, Inc.'s most recent earnings report was on October 30, 2025
When does AptarGroup, Inc. report earnings?
The next expected earnings date for AptarGroup, Inc. is February 5, 2026